secwatch.observer — SEC 8-K summary
======================================

Issuer:     Indaptus Therapeutics, Inc. (INDP)
CIK:        0001857044
Form:       8-K
Filed at:   2026-01-02T23:59:59+00:00
Accession:  0001493152-26-000106
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Three Indaptus Therapeutics directors resign pending stockholder vote on Lazar nominees
--------------------------------------------------------------------------------

- Directors Michael Newman, Mark Gilbert, Anthony Maddaluna resigned effective upon approval of David Lazar's nominees at next stockholder meeting.
- Resignations not due to any disagreement with Company, management, Board, or committees.
- Board changes likely part of ongoing activist or settlement with David Lazar.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1857044/000149315226000106/0001493152-26-000106-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1857044/000149315226000106/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-000106

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer